Hovione

Hovione is a global Contract Development and Manufacturing Organization (CDMO) that specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and Drug Product Intermediates. Founded in Portugal in 1959, the company has expanded to include manufacturing sites in the United States, Portugal, Ireland, China, and Macau, employing over 1,100 people. The company offers a range of services for pharmaceutical clients, focusing on bringing new and off-patent drugs to market. Hovione is known for its expertise in producing complex APIs, including highly potent compounds, and emphasizes quality, innovation, and regulatory compliance. Its product portfolio includes semi-synthetic tetracyclines, corticosteroids, and contrast agents, along with services for inhaled drugs, from API production to formulation development. Hovione serves a diverse clientele, including innovator pharmaceutical companies and generic drug manufacturers, and is committed to scientific excellence and social responsibility as a Certified B Corporation.